- ►duanessolution.com H Sakaguchi, Y Ikuno, F Gomi, M Kamei, M … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: The mean BCVA was 0.26 before treatment and 0.51 at the last visit (p =
0.009). The BCVA improved to two or more lines in six eyes (75%) and remained
the same in two eyes (25%). Leakage from the mCNV on fluorescein ... Cited by 72 - Related articles - BL Direct - All 7 versions
- ►prsjournal.com I Yamamoto, AH Rogers, E Reichel, PA Yates, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: There were 11 eyes of 9 patients. 5 of 11 eyes had been treated
previously with photodynamic therapy. Pre-injection visual acuity measured 20/50
to 20/100 in 6 eyes and 20/200 or worse in 5 eyes. After a mean follow-up ... Cited by 77 - Related articles - BL Direct - All 6 versions
- ►prsjournal.com [PDF] K Laud, RF Spaide, KB Freund, J Slakter, JM … - Retina, 2006 - pdfs.journals.lww.com Pathologic myopia is a leading cause of visual loss in younger individuals
worldwide. The most significant complication is choroidal neovascularization
(CNV), which often leads to rapid visual loss. CNV typically occurs near ... Cited by 35 - Related articles - BL Direct - All 4 versions
- ►prsjournal.com ML HERNÁNDEZ-ROJAS, H Quiroz-Mercado, … - Retina, 2007 - journals.lww.com Methods: In this prospective interventional case series, patients were treated
with 2.5 mg of intravitreal bevacizumab and followed for 3 months.
Best-corrected visual acuity (BCVA), optical coherence tomography (OCT), ... Cited by 34 - Related articles - BL Direct - All 3 versions
WM Chan, TYY Lai, AL Wong, DTL Liu, DSC … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: At 1 year, the logMAR best-corrected visual acuity (BCVA) for the
combined PDT with IVTA group changed from 0.62 to 0.61 (p = 0.74), whereas that
for the monotherapy group changed from 0.61 to 0.67 (p = 0.33). The mean ... Cited by 22 - Related articles - BL Direct - All 5 versions
JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ... Cited by 16 - Related articles - All 8 versions
S Mandal, P Venkatesh, R Sampangi, S Garg - European journal of ophthalmology - ncbi.nlm.nih.gov PURPOSE: To evaluate the short-term efficacy and safety of intravitreal
bevacizumab in myopic choroidal neovascularization (mCNV). METHODS: In this
noncomparative, consecutive, interventional case series, 12 eyes of 11 ... Cited by 19 - Related articles - BL Direct - All 3 versions
T Yoshida, K Ohno-Matsui, K Yasuzumi, A … - Ophthalmology, 2003 - Elsevier Presented in part as a poster at the annual meeting of the Association for
Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2002. ...
To clarify the long-term visual outcome of choroidal neovascularization ... Cited by 57 - Related articles - All 14 versions
